Why it matters: There have been some documented cases of reinfection leading to concern survivors don't gain any immunity.

While there remain questions on how much or how long immunity lasts and what the impact of variants will be, this large set of observational data bolsters evidence there's some protection.

Get market news worthy of your time with Axios Markets.